aalto1 untyped-item.component.html

Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools

Loading...
Thumbnail Image

Access rights

openAccess
CC BY

Creative Commons license

Except where otherwised noted, this item's license is described as openAccess
publishedVersion

URL

Journal Title

Journal ISSN

Volume Title

A2 Katsausartikkeli tieteellisessä aikakauslehdessä

Authors

Yadav, Deepshikha
Agarwal, Shriya
Pancham, Pranav
Jindal, Divya
Agarwal, Vinayak
Dubey, Premshankar Kumar
Jha, Saurabh K.
Mani, Shalini
Rachana
Dey, Abhijit

Major/Subject

Mcode

Degree programme

Language

en

Pages

28

Series

Immuno, Volume 2, issue 2, pp. 344-371

Abstract

The pathogenesis of COVID-19 is complicated by immune dysfunction. The impact of immune-based therapy in COVID-19 patients has been well documented, with some notable studies on the use of anti-cytokine medicines. However, the complexity of disease phenotypes, patient heterogeneity and the varying quality of evidence from immunotherapy studies provide problems in clinical decision-making. This review seeks to aid therapeutic decision-making by giving an overview of the immunological responses against COVID-19 disease that may contribute to the severity of the disease. We have extensively discussed theranostic methods for COVID-19 detection. With advancements in technology, bioinformatics has taken studies to a higher level. The paper also discusses the application of bioinformatics and machine learning tools for the diagnosis, vaccine design and drug repurposing against SARS-CoV-2.

Description

Publisher Copyright: © 2022 by the authors.

Other note

Citation

Yadav, D, Agarwal, S, Pancham, P, Jindal, D, Agarwal, V, Dubey, P K, Jha, S K, Mani, S, Rachana, Dey, A, Jha, N K, Kesari, K K & Singh, M 2022, 'Probing the Immune System Dynamics of the COVID-19 Disease for Vaccine Designing and Drug Repurposing Using Bioinformatics Tools', Immuno, vol. 2, no. 2, pp. 344-371. https://doi.org/10.3390/immuno2020022

Endorsement

Review

Supplemented By

Referenced By